Accordingly, an increased frequency of CD4+ T cells with specificity for bullous pemphigoid antigen 2 (BPAG2) was observed in patients with bullous pemphigoid, an HLA-class II-associated blistering skin disease mediated by antibodies against BPAG2 (97, 98). Here, COL17A1 is linked to bullous pemphigoid.